These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34219710)

  • 1. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    Squitti R; Faller P; Hureau C; Granzotto A; White AR; Kepp KP
    J Alzheimers Dis; 2021; 83(1):23-41. PubMed ID: 34219710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper and Alzheimer's Disease.
    Mathys ZK; White AR
    Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
    Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
    J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
    Solovyev N; El-Khatib AH; Costas-Rodríguez M; Schwab K; Griffin E; Raab A; Platt B; Theuring F; Vogl J; Vanhaecke F
    J Biol Chem; 2021; 296():100292. PubMed ID: 33453282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of metal ions in the pathogenesis of Alzheimer's disease.
    Wang L; Yin YL; Liu XZ; Shen P; Zheng YG; Lan XR; Lu CB; Wang JZ
    Transl Neurodegener; 2020; 9():10. PubMed ID: 32266063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metals and amyloid-beta in Alzheimer's disease.
    Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
    Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating
    Squitti R; Ventriglia M; Simonelli I; Bonvicini C; Costa A; Perini G; Binetti G; Benussi L; Ghidoni R; Koch G; Borroni B; Albanese A; Sensi SL; Rongioletti M
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives.
    Robakis NK
    Neurobiol Aging; 2011 Mar; 32(3):372-9. PubMed ID: 20594619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains.
    Lin CJ; Huang HC; Jiang ZF
    Brain Res Bull; 2010 Jul; 82(5-6):235-42. PubMed ID: 20598459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
    Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
    J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is interaction of amyloid β-peptides with metals involved in cognitive activity?
    Tamano H; Takeda A
    Metallomics; 2015 Aug; 7(8):1205-12. PubMed ID: 25959547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.
    Miller LM; Wang Q; Telivala TP; Smith RJ; Lanzirotti A; Miklossy J
    J Struct Biol; 2006 Jul; 155(1):30-7. PubMed ID: 16325427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histidine composition of the amyloid-β domain, but not the E1 copper binding domain, modulates β-secretase processing of amyloid-β protein precursor in Alzheimer's disease.
    Gough M; Blanthorn-Hazell S; Parkin ET
    J Alzheimers Dis; 2015; 43(4):1163-8. PubMed ID: 25171714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies.
    Chen WT; Hong CJ; Lin YT; Chang WH; Huang HT; Liao JY; Chang YJ; Hsieh YF; Cheng CY; Liu HC; Chen YR; Cheng IH
    PLoS One; 2012; 7(4):e35807. PubMed ID: 22558227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.